Benzamide Derivatives Targeting the Cell Division Protein FtsZ : Modifications of the Linker and the Benzodioxane Scaffold and Their Effects on Antimicrobial Activity

Filamentous temperature-sensitive Z (FtsZ) is a prokaryotic protein with an essential role in the bacterial cell division process. It is widely conserved and expressed in both Gram-positive and Gram-negative strains. In the last decade, several research groups have pointed out molecules able to target FtsZ in Staphylococcus aureus, Bacillus subtilis and other Gram-positive strains, with sub-micromolar Minimum Inhibitory Concentrations (MICs). Conversely, no promising derivatives active on Gram-negatives have been found up to now. Here, we report our results on a class of benzamide compounds, which showed comparable inhibitory activities on both S. aureus and Escherichia coli FtsZ, even though they proved to be substrates of E. coli efflux pump AcrAB, thus affecting the antimicrobial activity. These surprising results confirmed how a single molecule can target both species while maintaining potent antimicrobial activity. A further computational study helped us decipher the structural features necessary for broad spectrum activity and assess the drug-like profile and the on-target activity of this family of compounds.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:9

Enthalten in:

Antibiotics (Basel, Switzerland) - 9(2020), 4 vom: 04. Apr.

Sprache:

Englisch

Beteiligte Personen:

Straniero, Valentina [VerfasserIn]
Suigo, Lorenzo [VerfasserIn]
Casiraghi, Andrea [VerfasserIn]
Sebastián-Pérez, Victor [VerfasserIn]
Hrast, Martina [VerfasserIn]
Zanotto, Carlo [VerfasserIn]
Zdovc, Irena [VerfasserIn]
De Giuli Morghen, Carlo [VerfasserIn]
Radaelli, Antonia [VerfasserIn]
Valoti, Ermanno [VerfasserIn]

Links:

Volltext

Themen:

1,4-benzodioxane
1,4-benzoxathiane
Benzamide
Cell division protein FtsZ
Escherichia coli N43
Journal Article
Multi-drug resistant Staphylococcus aureus

Anmerkungen:

Date Revised 28.09.2020

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.3390/antibiotics9040160

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM30845619X